1 week ago
Moderna (MRNA) Surges Nearly 8% as Q1 Revenue Crushes Wall Street Forecasts
Moderna (MRNA) shares surge 8% after Q1 revenue hits $389M, tripling year-over-year and beating estimates on strong international vaccine sales.
The post Moderna (MRNA) Surges Nearly 8% as Q1 Revenue Crushes Wall Street Forecasts appeared first on Blockonomi.
Source: Blockonomi →Related News
- 4 hours ago
Serve Robotics (SERV) Stock Slides Despite 578% Revenue Surge in Q1 2026
- 4 hours ago
Intel (INTC) Stock Soars to Record High on Apple Manufacturing Partnership
- 4 hours ago
Antelope Enterprise (AEHL) Stock Jumps 60% on Bitcoin Profits and Share Buyback...
- 5 hours ago
S&P 500 Market Concentration Deepens Amid Big Tech and AI Momentum
- 5 hours ago
Moderna (MRNA) Stock Jumps 16% Following Positive Flu Vaccine Results and Wall S...
